Old Web
English
Sign In
Acemap
>
authorDetail
>
S Khan
S Khan
University of Pennsylvania
Immunology
Regimen
Rituximab
Lupus erythematosus
Medicine
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An open-label safety and efficacy study of an anti-CD20 antibody (rituximab, Rituxan) for anti-B-cell therapy in the treatment of systemic lupus erythematosus
2004
Arthritis Research & Therapy
Robert A. Eisenberg
S Khan
J Stansberry
Donald E. Tsai
S Kolasinski
E Rieder
Brian L. Kotzin
Rj Looney
C Strieber
Daniel A. Albert
Show All
Source
Cite
Save
Citations (1)
A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
2003
Arthritis Research & Therapy
Robert A. Eisenberg
Daniel A. Albert
J Stansberry
Donald E. Tsai
S Kolasinski
S Khan
Show All
Source
Cite
Save
Citations (11)
1